UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT
COMPANY
INVESTMENT COMPANY ACT FILE NUMBER: 811-23144
NAME OF REGISTRANT: NexPoint Healthcare Opportunities
Fund
ADDRESS OF PRINCIPAL EXECUTIVE OFFICES: 300 Crescent Court
Suite 700
Dallas, TX 75201
NAME AND ADDRESS OF AGENT FOR SERVICE: NexPoint Advisors, L.P.
300 Crescent Court
Suite 700
Dallas, TX 75201
REGISTRANT'S TELEPHONE NUMBER: 972-628-4100
DATE OF FISCAL YEAR END: 12/31
DATE OF REPORTING PERIOD: 07/01/2018 - 06/30/2019
The fund held no voting securities during the reporting period and did not vote any securities or have
any securities that were subject to a vote during the reporting period.
NexPoint Healthcare Opportunities Fund
--------------------------------------------------------------------------------------------------------------------------
ABBOTT LABORATORIES Agenda Number: 934941736
--------------------------------------------------------------------------------------------------------------------------
Security: 002824100
Meeting Type: Annual
Meeting Date: 26-Apr-2019
Ticker: ABT
ISIN: US0028241000
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1. DIRECTOR
R.J. Alpern Mgmt No vote
R.S. Austin Mgmt No vote
S.E. Blount Mgmt No vote
M.A. Kumbier Mgmt No vote
E.M. Liddy Mgmt No vote
N. McKinstry Mgmt No vote
P.N. Novakovic Mgmt No vote
W.A. Osborn Mgmt No vote
S.C. Scott III Mgmt No vote
D.J. Starks Mgmt No vote
J.G. Stratton Mgmt No vote
G.F. Tilton Mgmt No vote
M.D. White Mgmt No vote
2. Ratification of Ernst & Young LLP as Mgmt No vote
Auditors
3. Say on Pay - An Advisory Vote to Approve Mgmt No vote
Executive Compensation
4. Shareholder Proposal - Independent Board Shr No vote
Chairman
--------------------------------------------------------------------------------------------------------------------------
ACADIA HEALTHCARE COMPANY, INC. Agenda Number: 934950189
--------------------------------------------------------------------------------------------------------------------------
Security: 00404A109
Meeting Type: Annual
Meeting Date: 02-May-2019
Ticker: ACHC
ISIN: US00404A1097
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1.1 Election of Director: William F. Grieco Mgmt No vote
1.2 Election of Director: Reeve B. Waud Mgmt No vote
2. Advisory vote on the compensation of the Mgmt No vote
Company's named executive officers as
presented in the Proxy Statement.
3. Advisory vote on the frequency of the Mgmt No vote
advisory vote on the compensation of the
Company's named executive officers.
4. Ratify the appointment of Ernst & Young LLP Mgmt No vote
as the Company's independent registered
public accounting firm for the fiscal year
ending December 31, 2019.
--------------------------------------------------------------------------------------------------------------------------
AERIE PHARMACEUTICALS, INC. Agenda Number: 934982679
--------------------------------------------------------------------------------------------------------------------------
Security: 00771V108
Meeting Type: Annual
Meeting Date: 23-May-2019
Ticker: AERI
ISIN: US00771V1089
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1. DIRECTOR
G. D. Cagle, Ph.D. Mgmt For For
R. Croarkin Mgmt For For
2. Ratification of the appointment of Mgmt For For
PricewaterhouseCoopers LLP as the Company's
independent registered public accounting
firm for the fiscal year ending December
31, 2019.
3. To approve, by a non-binding vote, the Mgmt For For
compensation of our named executive
officers ("say-on-pay").
--------------------------------------------------------------------------------------------------------------------------
AMARIN CORPORATION PLC Agenda Number: 935013196
--------------------------------------------------------------------------------------------------------------------------
Security: 023111206
Meeting Type: Annual
Meeting Date: 20-May-2019
Ticker: AMRN
ISIN: US0231112063
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1. To re-elect Mr. Jan van Heek as a director. Mgmt For For
2. To re-elect Ms. Kristine Peterson as a Mgmt For For
director.
3. To hold an advisory (non-binding) vote to Mgmt For For
approve the compensation of the Company's
"named executive officers" as described in
full in the "Executive Compensation
Discussion and Analysis" section, the
tabular disclosure regarding such
compensation, and the accompanying
narrative disclosure on pages 25 to 55 of
the accompanying Proxy Statement.
4. To appoint Ernst & Young LLP as auditors of Mgmt For For
the Company to hold office until the
conclusion of the next general meeting at
which accounts are laid before the Company
and to authorize the Audit Committee of the
Board of Directors of the Company to fix
the auditors' remuneration as described in
full on pages 9 to 10 of the accompanying
Proxy Statement.
5. To generally and unconditionally Mgmt Against Against
reauthorize the Board of Directors of the
Company to exercise all powers of the
Company to allot shares in the Company or
grant rights to subscribe for or to convert
any security into shares of the Company up
to an aggregate nominal amount of GBP
148,000,000 (being the aggregate nominal
amount of GBP 125,000,000 in respect of
ordinary shares and GBP 23,000,000 in
respect of preference shares) as described
in full on pages 11 to 12 of the
accompanying Proxy Statement.
6. To, subject to the passing of Resolution Mgmt Against Against
No. 5, disapply statutory pre-emption
rights otherwise applicable to shares in
the Company allotted by the Board of
Directors, up to an aggregate nominal
amount of GBP 148,000,000 (being the
aggregate nominal amount of GBP 125,000,000
in respect of ordinary shares and GBP
23,000,000 in respect of preference shares)
as described in full on pages 13 to 14 of
the accompanying Proxy Statement.
--------------------------------------------------------------------------------------------------------------------------
AMGEN INC. Agenda Number: 934979266
--------------------------------------------------------------------------------------------------------------------------
Security: 031162100
Meeting Type: Annual
Meeting Date: 21-May-2019
Ticker: AMGN
ISIN: US0311621009
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1a. Election of Director: Dr. Wanda M. Austin Mgmt For For
1b. Election of Director: Mr. Robert A. Bradway Mgmt For For
1c. Election of Director: Dr. Brian J. Druker Mgmt For For
1d. Election of Director: Mr. Robert A. Eckert Mgmt For For
1e. Election of Director: Mr. Greg C. Garland Mgmt For For
1f. Election of Director: Mr. Fred Hassan Mgmt For For
1g. Election of Director: Dr. Rebecca M. Mgmt For For
Henderson
1h. Election of Director: Mr. Charles M. Mgmt For For
Holley, Jr.
1i. Election of Director: Dr. Tyler Jacks Mgmt For For
1j. Election of Director: Ms. Ellen J. Kullman Mgmt For For
1k. Election of Director: Dr. Ronald D. Sugar Mgmt For For
1l. Election of Director: Dr. R. Sanders Mgmt For For
Williams
2. Advisory vote to approve our executive Mgmt For For
compensation.
3. To ratify the selection of Ernst & Young Mgmt For For
LLP as our independent registered public
accountants for the fiscal year ending
December 31, 2019.
--------------------------------------------------------------------------------------------------------------------------
BIO-RAD LABORATORIES, INC. Agenda Number: 934985904
--------------------------------------------------------------------------------------------------------------------------
Security: 090572207
Meeting Type: Annual
Meeting Date: 29-Apr-2019
Ticker: BIO
ISIN: US0905722072
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1.1 Election of Director: Arnold A. Pinkston Mgmt For For
1.2 Election of Director: Melinda Litherland Mgmt For For
2. PROPOSAL to ratify the selection of KPMG Mgmt For For
LLP to serve as the Company's independent
auditors.
--------------------------------------------------------------------------------------------------------------------------
CHARLES RIVER LABORATORIES INTL., INC. Agenda Number: 934978579
--------------------------------------------------------------------------------------------------------------------------
Security: 159864107
Meeting Type: Annual
Meeting Date: 21-May-2019
Ticker: CRL
ISIN: US1598641074
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1A. Election of Director: James C. Foster Mgmt For For
1B. Election of Director: Robert J. Bertolini Mgmt For For
1C. Election of Director: Stephen D. Chubb Mgmt For For
1D. Election of Director: Deborah T. Kochevar Mgmt For For
1E. Election of Director: Martin W. MacKay Mgmt For For
1F. Election of Director: Jean-Paul Mangeolle Mgmt For For
1G. Election of Director: George E. Massaro Mgmt For For
1H. Election of Director: George M. Milne, Jr. Mgmt For For
1I. Election of Director: C. Richard Reese Mgmt For For
1J. Election of Director: Richard F. Wallman Mgmt For For
2. Say on Pay - An advisory vote to approve Mgmt For For
our executive compensation.
3. Proposal to ratify the appointment of Mgmt For For
PricewaterhouseCoopers LLP as our
independent registered public accountants
for the fiscal year ending December 28,
2019.
--------------------------------------------------------------------------------------------------------------------------
COLLEGIUM PHARMACEUTICAL, INC. Agenda Number: 934946344
--------------------------------------------------------------------------------------------------------------------------
Security: 19459J104
Meeting Type: Annual
Meeting Date: 25-Apr-2019
Ticker: COLL
ISIN: US19459J1043
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1A Election of Class I Director to hold office Mgmt No vote
until the 2022 Annual Meeting: John A.
Fallon, M.D.
1B Election of Class I Director to hold office Mgmt No vote
until the 2022 Annual Meeting: John G.
Freund, M.D.
1C Election of Class I Director to hold office Mgmt No vote
until the 2022 Annual Meeting: David
Hirsch, M.D., Ph.D.
1D Election of Class II Director to hold Mgmt No vote
office until the 2020 Annual Meeting:
Joseph Ciaffoni
2. Approval of, on an advisory basis, the Mgmt No vote
compensation of the Company's named
executive officers
3. Indication of, on an advisory basis, the Mgmt No vote
preferred frequency of future shareholder
advisory votes on the compensation of the
Company's named executive officers
4. Ratification of Deloitte & Touche LLP as Mgmt No vote
the Company's independent registered public
accounting firm for the fiscal year ending
December 31, 2019
--------------------------------------------------------------------------------------------------------------------------
HERON THERAPEUTICS, INC. Agenda Number: 935021232
--------------------------------------------------------------------------------------------------------------------------
Security: 427746102
Meeting Type: Annual
Meeting Date: 18-Jun-2019
Ticker: HRTX
ISIN: US4277461020
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1A Election of Director: Kevin Tang Mgmt For For
1B Election of Director: Barry Quart, Pharm.D. Mgmt For For
1C Election of Director: Craig Johnson Mgmt For For
1D Election of Director: John Poyhonen Mgmt For For
1E Election of Director: Christian Waage Mgmt For For
2. To ratify the appointment of OUM & Co. LLP Mgmt For For
as the Company's independent registered
public accounting firm for the year ending
December 31, 2019.
3. To approve, on an advisory basis, Mgmt Against Against
compensation paid to the Company's Named
Executive Officers during the year ended
December 31, 2018.
4. To approve, on an advisory basis, the Mgmt 1 Year For
frequency of future advisory votes to
approve compensation paid to the Company's
Named Executive Officers.
5. To amend the Company's 2007 Amended and Mgmt Against Against
Restated Equity Incentive Plan to increase
the number of shares of common stock
authorized for issuance thereunder from
18,800,000 to 25,800,000.
6. To amend the Company's 1997 Employee Stock Mgmt For For
Purchase Plan, as amended to increase the
number of shares of common stock authorized
for issuance thereunder from 475,000 to
775,000.
--------------------------------------------------------------------------------------------------------------------------
HUMANA INC. Agenda Number: 934935694
--------------------------------------------------------------------------------------------------------------------------
Security: 444859102
Meeting Type: Annual
Meeting Date: 18-Apr-2019
Ticker: HUM
ISIN: US4448591028
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1a) Election of Director: Kurt J. Hilzinger Mgmt No vote
1b) Election of Director: Frank J. Bisignano Mgmt No vote
1c) Election of Director: Bruce D. Broussard Mgmt No vote
1d) Election of Director: Frank A. D'Amelio Mgmt No vote
1e) Election of Director: Karen B. DeSalvo, Mgmt No vote
M.D.
1f) Election of Director: W. Roy Dunbar Mgmt No vote
1g) Election of Director: David A. Jones, Jr. Mgmt No vote
1h) Election of Director: William J. McDonald Mgmt No vote
1i) Election of Director: James J. O'Brien Mgmt No vote
1j) Election of Director: Marissa T. Peterson Mgmt No vote
2. The ratification of the appointment of Mgmt No vote
PricewaterhouseCoopers LLP as the Company's
independent registered public accounting
firm.
3. The approval of the compensation of the Mgmt No vote
named executive officers as disclosed in
the 2019 proxy statement.
4. The approval of the Amended and Restated Mgmt No vote
Humana Inc. Stock Incentive Plan.
--------------------------------------------------------------------------------------------------------------------------
LHC GROUP, INC. Agenda Number: 935010289
--------------------------------------------------------------------------------------------------------------------------
Security: 50187A107
Meeting Type: Annual
Meeting Date: 13-Jun-2019
Ticker: LHCG
ISIN: US50187A1079
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1. DIRECTOR
Monica F. Azare Mgmt For For
Teri G. Fontenot Mgmt For For
John L. Indest Mgmt For For
2. To adopt, on an advisory basis, a Mgmt For For
resolution approving the compensation of
our named executive officers.
3. The ratification of the selection of KPMG Mgmt For For
LLP as the independent registered public
accounting firm for the fiscal year ending
December 31, 2019.
--------------------------------------------------------------------------------------------------------------------------
MOLINA HEALTHCARE, INC. Agenda Number: 934945936
--------------------------------------------------------------------------------------------------------------------------
Security: 60855R100
Meeting Type: Annual
Meeting Date: 08-May-2019
Ticker: MOH
ISIN: US60855R1005
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1A. Election of Class II Director: Barbara L. Mgmt No vote
Brasier
1B. Election of Class II Director: Steven J. Mgmt No vote
Orlando
1C. Election of Class II Director: Richard C. Mgmt No vote
Zoretic
2. To consider and approve, on a non-binding, Mgmt No vote
advisory basis, the compensation of our
named executive officers.
3. To adopt amendments to the Company's Mgmt No vote
Certificate of Incorporation, as amended,
to phase out and eliminate the classified
Board of Directors to provide for the
annual election of all directors.
4. To approve the Molina Healthcare, Inc. 2019 Mgmt No vote
Equity Incentive Plan.
5. To approve the Molina Healthcare, Inc. 2019 Mgmt No vote
Employee Stock Purchase Plan.
6. To ratify the appointment of Ernst & Young Mgmt No vote
LLP as our independent registered public
accounting firm for 2019.
--------------------------------------------------------------------------------------------------------------------------
PARATEK PHARMACEUTICALS, INC. Agenda Number: 935012411
--------------------------------------------------------------------------------------------------------------------------
Security: 699374302
Meeting Type: Annual
Meeting Date: 12-Jun-2019
Ticker: PRTK
ISIN: US6993743029
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1. DIRECTOR
Thomas J. Dietz, Ph.D. Mgmt For For
Timothy R. Franson, M.D Mgmt For For
Evan Loh, M.D. Mgmt For For
2. To ratify the selection by the Audit Mgmt For For
Committee of the Board of Directors of
Ernst & Young LLP as our independent
registered public accounting firm for the
year ending December 31, 2019.
--------------------------------------------------------------------------------------------------------------------------
PORTOLA PHARMACEUTICALS, INC. Agenda Number: 935007371
--------------------------------------------------------------------------------------------------------------------------
Security: 737010108
Meeting Type: Annual
Meeting Date: 13-Jun-2019
Ticker: PTLA
ISIN: US7370101088
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1. DIRECTOR
Laura Brege Mgmt For For
Scott Garland Mgmt For For
Hollings Renton Mgmt For For
2. To approve, on an advisory basis, the Mgmt For For
compensation of the Company's named
executive officers, as disclosed in this
proxy statement.
3. To ratify the selection of Ernst & Young Mgmt For For
LLP as the Company's independent registered
public accounting firm for the fiscal year
ending December 31, 2019.
--------------------------------------------------------------------------------------------------------------------------
TG THERAPEUTICS, INC. Agenda Number: 935011938
--------------------------------------------------------------------------------------------------------------------------
Security: 88322Q108
Meeting Type: Annual
Meeting Date: 13-Jun-2019
Ticker: TGTX
ISIN: US88322Q1085
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1. DIRECTOR
Laurence Charney Mgmt For For
Yann Echelard Mgmt For For
William J. Kennedy Mgmt For For
Kenneth Hoberman Mgmt For For
Daniel Hume Mgmt For For
Mark Schoenebaum, M.D. Mgmt Withheld Against
Michael S. Weiss Mgmt For For
2. To ratify the appointment of CohnReznick Mgmt For For
LLP as our independent registered public
accounting firm for the year ending
December 31, 2019.
3. An advisory vote to approve the Mgmt Against Against
compensation of our named executive
officers.
4. To recommend, by non-binding vote, the Mgmt 1 Year Against
frequency of executive compensation votes.
5. A shareholder proposal on an amendment to Shr For Against
the Company's articles/bylaws to require
majority vote in director elections.
--------------------------------------------------------------------------------------------------------------------------
THERMO FISHER SCIENTIFIC INC. Agenda Number: 934979519
--------------------------------------------------------------------------------------------------------------------------
Security: 883556102
Meeting Type: Annual
Meeting Date: 22-May-2019
Ticker: TMO
ISIN: US8835561023
--------------------------------------------------------------------------------------------------------------------------
Prop.# Proposal Proposal Proposal Vote For/Against
Type Management
1a. Election of Director: Marc N. Casper Mgmt No vote
1b. Election of Director: Nelson J. Chai Mgmt No vote
1c. Election of Director: C. Martin Harris Mgmt No vote
1d. Election of Director: Tyler Jacks Mgmt No vote
1e. Election of Director: Judy C. Lewent Mgmt No vote
1f. Election of Director: Thomas J. Lynch Mgmt No vote
1g. Election of Director: Jim P. Manzi Mgmt No vote
1h. Election of Director: James C. Mullen Mgmt No vote
1i. Election of Director: Lars R. Sorensen Mgmt No vote
1j. Election of Director: Scott M. Sperling Mgmt No vote
1k. Election of Director: Elaine S. Ullian Mgmt No vote
1l. Election of Director: Dion J. Weisler Mgmt No vote
2. An advisory vote to approve named executive Mgmt No vote
officer compensation.
3. Ratification of the Audit Committee's Mgmt No vote
selection of PricewaterhouseCoopers LLP as
the Company's independent auditors for
2019.
* Management position unknown
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
(Registrant) NexPoint Healthcare Opportunities Fund
By (Signature) /s/ Lauren Thedford
Name Lauren Thedford
Title Secretary
Date 08/21/2019